Cargando…
Diagnostic value of clusterin immunostaining in hepatocellular carcinoma
BACKGROUND: Histologic distinction between well differentiated hepatocellular carcinoma (HCC) and benign hepatocellular mass lesions is a known challenge. Existing biomarkers are of limited diagnostic value. Our previous studies observed an enhanced canalicular expression pattern of clusterin (CLU)...
Autores principales: | Li, Yuan, Liu, Fangfang, Zhou, Wendi, Zhang, Sharon, Chu, Peiguo, Lin, Fan, Wang, Hanlin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559739/ https://www.ncbi.nlm.nih.gov/pubmed/33054843 http://dx.doi.org/10.1186/s13000-020-01041-8 |
Ejemplares similares
-
No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
por: Silajdžić, Edina, et al.
Publicado: (2012) -
Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020) -
The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1
por: Radwan, Nehal A, et al.
Publicado: (2012) -
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value
por: Vannucchi, A M, et al.
Publicado: (2014) -
Clusterin Expression in Colorectal Carcinomas
por: Téllez, Teresa, et al.
Publicado: (2023)